Search alternatives:
nn decrease » _ decrease (Expand Search), mean decrease (Expand Search), gy decreased (Expand Search)
we decrease » _ decrease (Expand Search), mean decrease (Expand Search), teer decrease (Expand Search)
0 decrease » _ decrease (Expand Search), _ decreased (Expand Search), _ decreases (Expand Search)
a decrease » _ decrease (Expand Search), _ decreased (Expand Search), _ decreases (Expand Search)
51 0 » 1 0 (Expand Search), 01 0 (Expand Search)
nn decrease » _ decrease (Expand Search), mean decrease (Expand Search), gy decreased (Expand Search)
we decrease » _ decrease (Expand Search), mean decrease (Expand Search), teer decrease (Expand Search)
0 decrease » _ decrease (Expand Search), _ decreased (Expand Search), _ decreases (Expand Search)
a decrease » _ decrease (Expand Search), _ decreased (Expand Search), _ decreases (Expand Search)
51 0 » 1 0 (Expand Search), 01 0 (Expand Search)
-
161
-
162
-
163
-
164
-
165
Primers for real-time PCR (rat).
Published 2024“…<i>Jag2</i> upregulation was first confirmed in rats with sustained hypoxia-induced PH using publicly available gene expression data, experimental PH rat models and hypoxia induced rat PASMCs. Jag2 deficiency decreased oxidative stress injury, peripheral pulmonary vascular remodeling (0.276±0.020 vs. 0.451±0.033 μm, <i>P</i><0.001, <50μm), and right ventricular systolic pressure (36.8±3.033 vs. 51.8±4.245 mmHg, <i>P</i><0.001) in the chronic hypoxia-induced rat model of PH. …”
-
166
Raw image of western blots.
Published 2024“…<i>Jag2</i> upregulation was first confirmed in rats with sustained hypoxia-induced PH using publicly available gene expression data, experimental PH rat models and hypoxia induced rat PASMCs. Jag2 deficiency decreased oxidative stress injury, peripheral pulmonary vascular remodeling (0.276±0.020 vs. 0.451±0.033 μm, <i>P</i><0.001, <50μm), and right ventricular systolic pressure (36.8±3.033 vs. 51.8±4.245 mmHg, <i>P</i><0.001) in the chronic hypoxia-induced rat model of PH. …”
-
167
S1 Data -
Published 2024“…Moreover, it is unclear how within-subject time course reliability limits the robust detection of connectivity on the group level. We estimated connectivity from a working memory task. …”
-
168
-
169
Data_Sheet_1_Marathon Running Increases Synthesis and Decreases Catabolism of Joint Cartilage Type II Collagen Accompanied by High-Energy Demands and an Inflamatory Reaction.PDF
Published 2021“…Mean sC2C levels (220.83 ± 39.50 ng/ml) decreased post-race (188.67 ± 38.52 ng/ml) (p = 0.002). …”
-
170
-
171
-
172
Exercise testing criteria to diagnose lower extremity peripheral artery disease assessed by computed-tomography angiography - Fig 2
Published 2019“…<p><b>ROC curves of the different tests to diagnose arterial stenosis ≥ 50% in the overall population (<i>n = 126 limbs</i>)</b> (A) and in the population with an ABI > 0.91 (<i>n = 60 limbs</i>) (B). …”
-
173
Exercise testing criteria to diagnose lower extremity peripheral artery disease assessed by computed-tomography angiography
Published 2019“…The receiver-operating-characteristic curve was used to define a cut-off point corresponding to the best area under the curve (AUC; [CI95%]) to detect arterial stenosis ≥50% as determined by the CTA.…”
-
174
-
175
-
176
-
177
Factors affecting the biology of <i>Pachycrepoideus vindemmiae</i> (Hymenoptera: Pteromalidae), a parasitoid of spotted-wing drosophila (<i>Drosophila suzukii</i>)
Published 2019“…Based on survival and host-killing capacity, we conclude that <i>P</i>. <i>vindemmiae</i> has a tremendous biocontrol potential against SWD. …”
-
178
Ivermectin as an adjuvant to anti-epileptic treatment in persons with onchocerciasis-associated epilepsy: A randomized proof-of-concept clinical trial
Published 2020“…<div><p>Introduction</p><p>Recent findings from onchocerciasis-endemic foci uphold that increasing ivermectin coverage reduces the epilepsy incidence, and anecdotal evidence suggests seizure frequency reduction in persons with onchocerciasis-associated epilepsy, when treated with ivermectin. We conducted a randomized clinical trial to assess whether ivermectin treatment decreases seizure frequency.…”
-
179
-
180